The cytochrome P450s metabolize a wide variety of xenobiotic and endogenous compounds. Biochemical, biophysical and computational approaches were applied to examine the structure-function relationships which govern the interactions of P450s with substrates and microsomal proteins. The kinetics of CO binding to P450 was used as a probe of P450 conformation and dynamics, to define the effect of various drugs and carcinogens on P450s. Of particular interest is the finding that human P450s 3A4 and 1A1, which respectively metabolize a variety of drugs and carcinogens, can assume alternate conformations. In contrast, the alcohol-inducible and carcinogen-metabolizing P450 2E1, which metabolizes a more narrow range of substrates, is more conformationally homogeneous. Ethanol was found to stabilize this P450 and modulate its substrate interactions. We employed molecular modeling to generate homology models of rat 2B1 and human P450 1A2. Peptide mimics of the P450 2B1 surface were prepares that disrupt the P450 interaction with its associated reductase. The active site structures of both P450s were consistent with their specificities toward known substrates or inhibitors. In conjunction with computational screening of a small molecule structure database, we are currently employing the P450 1A2 model to discover new inhibitors for this drug and carcinogen-metabolizing P450. In conjunction with previous work, our P450 homology models are consistent with P450-protein interactions as well as substrate specificity.

Agency
National Institute of Health (NIH)
Institute
Division of Basic Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC005318-18
Application #
6433017
Study Section
(LM)
Project Start
Project End
Budget Start
Budget End
Support Year
18
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Michl, Josef; Scharf, Bruce; Schmidt, Anna et al. (2006) PNC-28, a p53-derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo. Int J Cancer 119:1577-85
Chie, Lyndon; Friedman, Fred K; Duncan, Thomas et al. (2004) Loop domain peptides from the SOS ras-guanine nucleotide exchange protein, identified from molecular dynamics calculations, strongly inhibit ras signaling. Protein J 23:229-34
Friedman, Fred K; Robinson, Richard C; Dai, Renke (2004) Molecular modeling of mammalian cytochrome P450s. Front Biosci 9:2796-806
Bustin, Michael; Robinson, Richard C; Friedman, Fred K (2004) Immunochemical analysis of chromatin. Methods Enzymol 376:209-20
Duncan, Thomas; Chen, James M; Friedman, Fred K et al. (2004) Comparison of molecular dynamics averaged structures for complexes of normal and oncogenic ras-p21 with SOS nucleotide exchange protein, containing computed conformations for three crystallographically undefined domains, suggests a potential role of these Protein J 23:217-28
Chie, Lyndon; Adler, Victor; Friedman, Fred K et al. (2004) An effector peptide from glutathione-S-transferase-pi strongly and selectively blocks mitotic signaling by oncogenic ras-p21. Protein J 23:235-8
Dai, R; Pincus, M R; Friedman, F K (2000) Molecular modeling of mammalian cytochrome P450s. Cell Mol Life Sci 57:487-99
Smith, S V; Koley, A P; Dai, R et al. (2000) Conformational modulation of human cytochrome P450 2E1 by ethanol and other substrates: a CO flash photolysis study. Biochemistry 39:5731-7
Omata, Y; Dai, R; Smith, S V et al. (2000) Synthetic peptide mimics of a predicted topographical interaction surface: the cytochrome P450 2B1 recognition domain for NADPH-cytochrome P450 reductase. J Protein Chem 19:23-32
Wei, X; Dai, R; Zhai, S et al. (1999) Inhibition of human liver cytochrome P-450 1A2 by the class IB antiarrhythmics mexiletine, lidocaine, and tocainide. J Pharmacol Exp Ther 289:853-8